搜索临床试验以:dual IGF-1R/IR inhibition
总计3160个结果
-
LivaNova完全的在广泛的起搏器患者中评估 Symphony 2550 或 REPLYTM DR 的 AAISafeR/SafeR 算法的益处。意大利, 法国, 西班牙, 美国, 德国, 英国
-
National Council of Scientific and Technical Research...Merck Sharp & Dohme LLC完全的肠促胰岛素抑制血小板聚集
-
NHS Greater Glasgow and ClydeUniversity of Glasgow未知
-
Sheffield Teaching Hospitals NHS Foundation TrustMedical Research Council; Hologic, Inc.完全的
-
Royal Brompton & Harefield NHS Foundation TrustUniversity Hospital Tuebingen终止
-
University Medical Center Groningen终止
-
Universidade Federal de Sao Carlos完全的
-
Institut de Recherches Cliniques de MontrealMontreal Children's Hospital of the MUHC完全的
-
Assistance Publique - Hôpitaux de ParisEuropean Union未知
-
Fondazione Evidence per Attività e Ricerche Cardiovascolari...终止
-
Mayo ClinicMedtronic完全的
-
Duke UniversityUniversity of North Carolina, Chapel Hill; University of North Carolina, Greensboro; UConn Health完全的
-
University Hospital, Clermont-FerrandDr. Gisèle PICKERING (MCU, PH) Center of clinical pharmacology/CIC Inserm-501 - Main investigator 和其他合作者未知
-
King Chulalongkorn Memorial Hospital完全的
-
UConn HealthPfizer; National Institute of Dental and Craniofacial Research (NIDCR)完全的
-
GlaxoSmithKline完全的
-
Orrin M Troum, M.D. and Medical AssociatesBristol-Myers Squibb完全的
-
University of Campinas, BrazilFundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de Desenvolvimento Científico...完全的